<DOC>
	<DOCNO>NCT01286532</DOCNO>
	<brief_summary>This six-month non-interventional prospective study various controller therapy child asthma outpatient clinical practice .</brief_summary>
	<brief_title>Asthma Children</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Child ( male female ) age 5 11 year inclusive Provision Subject Informed Consent Form anonymous data collection subsequent use ( must sign parent ) The child must include outpatient observation program medical institution establish bronchial asthma diagnosis least 1 year prior enrolment diagnose moderate severe bronchial asthma time enrolment The child must least one document bronchial asthma exacerbation previous 1 year ( include hospital admission bronchial asthma exacerbation , case daytime hospital treatment without overnight stay case oral administration glucocorticoid outpatient basis &gt; 3 consecutive day ) Outpatient receive step 3 controller treatment fix dose combination ICSs LABA treatment separate administration glucocorticoid LABA stable dos adequate control bronchial asthma symptoms The patient administer shortacting β2 agonist ( inhalational ) rapidly release methylxanthines ( oral ) dose approved respective age rescue ondemand therapy precede month Cystic fibrosis , α1antitrypsin deficiency congenital abnormality lung development Severe comorbidities affect patient 's overall performance In physician 's opinion , patient able comply protocol requirement Expected specific hyposensibilization within next 6 month Expected treatment health resort facility within next 6 month Other reason physician 's opinion prevent reliable assessment study treatment efficacy</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Asthma , Asthma Children</keyword>
</DOC>